Bausch Health Cos Total Current Assets 2010-2024 | BHC

Bausch Health Cos total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
Bausch Health Cos Annual Total Current Assets
(Millions of US $)
2023 $5,596
2022 $4,247
2021 $5,607
2020 $5,342
2019 $6,969
2018 $4,211
2017 $4,746
2016 $5,077
2015 $5,507
2014 $4,132
2013 $3,886
2012 $2,777
2011 $1,358
2010 $1,020
2009 $343
Bausch Health Cos Quarterly Total Current Assets
(Millions of US $)
2024-09-30 $5,351
2024-06-30 $5,211
2024-03-31 $5,396
2023-12-31 $5,596
2023-09-30 $5,048
2023-06-30 $4,461
2023-03-31 $4,237
2022-12-31 $4,247
2022-09-30 $4,010
2022-06-30 $5,417
2022-03-31 $5,836
2021-12-31 $5,607
2021-09-30 $5,324
2021-06-30 $5,450
2021-03-31 $5,392
2020-12-31 $5,342
2020-09-30 $5,671
2020-06-30 $5,278
2020-03-31 $5,504
2019-12-31 $6,969
2019-09-30 $4,305
2019-06-30 $4,467
2019-03-31 $4,275
2018-12-31 $4,211
2018-09-30 $4,742
2018-06-30 $4,639
2018-03-31 $4,724
2017-12-31 $4,746
2017-09-30 $5,944
2017-06-30 $5,992
2017-03-31 $5,333
2016-12-31 $5,077
2016-09-30 $5,674
2016-06-30 $5,818
2016-03-31 $6,234
2015-12-31 $5,507
2015-09-30 $6,996
2015-06-30 $6,345
2015-03-31 $16,192
2014-12-31 $4,132
2014-09-30 $4,414
2014-06-30 $5,164
2014-03-31 $3,950
2013-12-31 $3,886
2013-09-30 $3,848
2013-06-30 $4,532
2013-03-31 $2,370
2012-12-31 $2,777
2012-09-30 $1,714
2012-06-30 $1,630
2012-03-31 $1,532
2011-12-31 $1,358
2011-09-30 $1,099
2011-06-30 $1,046
2011-03-31 $1,275
2010-12-31 $1,020
2010-09-30 $1,300
2010-06-30 $414
2010-03-31 $339
2009-12-31 $343
2009-09-30 $250
2009-06-30 $246
2009-03-31 $468
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.009B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.350B 6.35
Dr Reddy's Laboratories (RDY) India $11.677B 22.35
BridgeBio Pharma (BBIO) United States $4.392B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.142B 12.88
Supernus Pharmaceuticals (SUPN) United States $1.978B 26.93
Taysha Gene Therapies (TSHA) United States $0.447B 31.14
Personalis (PSNL) United States $0.239B 0.00
Assembly Biosciences (ASMB) United States $0.094B 0.00
Sol-Gel Technologies (SLGL) Israel $0.013B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00